Faculty Opinions recommendation of Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.
2014 ◽
Vol 66
(11)
◽
pp. 1576-1585
◽
2016 ◽
Vol 24
(8)
◽
pp. 1589-1597
◽
2011 ◽
Vol 162
(4)
◽
pp. 708-716
◽
2011 ◽
Vol 29
(5)
◽
pp. 863-868
◽
2008 ◽
Vol 118
(24)
◽
pp. 2515-2522
◽
Keyword(s):
2006 ◽
Vol 10
(3)
◽
pp. 472-480
◽
2009 ◽
Vol 157
(2)
◽
pp. 352-360.e2
◽
1997 ◽
Vol 119
(37)
◽
pp. 8608-8615
◽